APA (7th ed.) Citation

Kappert, K., Böhm, M., Schmieder, R., Schumacher, H., Teo, K., Yusuf, S., . . . Unger, T. (2012). Impact of sex on cardiovascular outcome in patients at high cardiovascular risk: Analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects With Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET). Circulation (New York, N.Y.), 126(8), 934. https://doi.org/10.1161/CIRCULATIONAHA.111.086660

Chicago Style (17th ed.) Citation

Kappert, Kai, Michael Böhm, Roland Schmieder, Helmut Schumacher, Koon Teo, Salim Yusuf, Peter Sleight, and Thomas Unger. "Impact of Sex on Cardiovascular Outcome in Patients at High Cardiovascular Risk: Analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects With Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET)." Circulation (New York, N.Y.) 126, no. 8 (2012): 934. https://doi.org/10.1161/CIRCULATIONAHA.111.086660.

MLA (9th ed.) Citation

Kappert, Kai, et al. "Impact of Sex on Cardiovascular Outcome in Patients at High Cardiovascular Risk: Analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects With Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET)." Circulation (New York, N.Y.), vol. 126, no. 8, 2012, p. 934, https://doi.org/10.1161/CIRCULATIONAHA.111.086660.